Tumour angiogenesis: vascular growth and survival
- 1 July 2004
- Vol. 112 (7-8) , 431-440
- https://doi.org/10.1111/j.1600-0463.2004.apm11207-0804.x
Abstract
Angiogenesis starts at the edge of a malignant epithelial tumour concurrently with tumour cell invasion and stromatogenesis, i.e. the formation of specific connective tissue stroma amenable to easy penetration by endothelial and tumour cells. However, as the tumour continues its growth, the edge becomes the inner tumour area, and a new invading tumour front is formed by the multiplying malignant cells which outflank the initial edge. This process, which repeats itself again and again, forms the "relay race" model of tumour vascular growth and regression. At the heart of the tumour unfavourable environmental conditions prevail -- hypoxia, acidity, lack of nutrients, failure of waste removal, and apoptosis rather than proliferation. Blood vessels and tumour cells are greatly decreased, but do not vanish, as tumour cells are shifting to anaerobic glycolysis, and blood vessels are turning into anti-apoptotic pathways -- vascular survival ability (VSA). Thus, assessing vascular density (VD) by simply counting "hot spots" at the edge of a tumour, where conditions are most favourable, is futile; it may reflect tumour angiogenic activity (TAA), but is not representative of genuine tumour vasculature. By combining vessel counts at the invading tumour front with those of the inner tumour areas a complete picture of tumour VD can be achieved. The thus formed four patterns of vascularization, designated as "edvin" (edge vsinner tumour area), are: edvin 1: low TAA/low VSA; edvin 4: high TAA/high VSA; edvin 2: low TAA/high VSA; and edvin 3: high TAA/low VSA. It is expected that this scheme will prove useful in the field of chemoradiotherapy and anti-angiogenic treatment.Keywords
This publication has 49 references indexed in Scilit:
- Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapseInternational Journal of Cancer, 2003
- The vascular network of tumours — what is it not for?The Journal of Pathology, 2003
- Hypoxia-induced pathways in breast cancerMicroscopy Research and Technique, 2002
- Angiogenic co‐operation of VEGF and stromal cell TP in endometrial carcinomasThe Journal of Pathology, 2002
- Suppression of Vascular Endothelial Growth Factor-Mediated Endothelial Cell Protection by Survivin TargetingThe American Journal of Pathology, 2001
- Microvessel Organization and Structure in Experimental Brain Tumors: Microvessel Populations with Distinctive Structural and Functional PropertiesMicrovascular Research, 1999
- EditorialCardiovascular Research, 1999
- Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.The Journal of Experimental Medicine, 1994
- Tumours acquire their vasculature by vessel incorporation, not vessel ingrowthThe Journal of Pathology, 1987
- Transport of Macromolecules In Tumor MicrocirculationBiotechnology Progress, 1985